Healthcare investment is part of our DNA here at OneVentures. Our first fund, our first investment, our first exit and our first investor returns came from OneVentures’ Partners wanting to improve the quality of life of people around the world. Now, we have even stronger ambitions to accelerate the healthcare companies of tomorrow.
We look for entrepreneurs and ideas that not only deliver clear patient benefits, but also create accessibility and the democratisation of healthcare treatment for all people. We are interested in transformative technology that will deliver best-in-class patient outcomes with global reach and impact, advancing science, communication, care and patient experience.
We invest in entrepeneurs and technologies that have the potential transform healthcare and health outcomes globally with a focus on therapeutics, devices and diagnostics at or near clinical development. Our healthcare team look to partner with founders and CEOs who have a clear commercial, regulatory and reimbursement pathway, who have strong ESG principles as a foundation of their business.
Licenced under the Commonwealth Government’s Biomedical Translation Fund (BTF) programme, the fund targets investments of $10 to $20 million per company in Australian domiciled companies. The OneVentures team provides support to drive these opportunities through the clinical, regulatory and reimbursement processes to achieve prominence in global markets.
The OneVentures healthcare team has a strong history of biomedical entrepreneurship, with experience commercialising biomedical innovation across the United States, Europe, United Kingdom and Australia.
OneVentures’ investing strategy focuses on investing to milestones – to ensure we are only partnering with those companies that are performing and achieving key validation steps. We look towards proof of clinical efficacy and safety, backed by quality science with a clear regulatory and reimbursement path.
The OneVentures team have a hands on approach with our investments, and believe in the quality of people and relationships to deliver long term success. With a history of achievement in transforming ideas, technologies and products into successful businesses, our collaborative approach looks to deliver successful outcomes for all our stakeholders.
MBBS(Hons), MD, FRACP
BAgrSc(Hons), M.P.S, GAICD
Brisbane, AU
BSc(Hons), MSc, PhD
BSc(Hons), MBA, GAICD
BSc (Hons), PhD
Melbourne, AU
Paranta Biosciences
Glutagen
PhD, Pathobiology
“I first met the OneVentures team in July 2018. They quickly impressed me with their broad knowledge and capabilities. Shortly afterwards, they led our Series C round. It has been a pleasure to build the company with the support of Paul, Sarah, Michelle, and Gabriel, and their LP’s over the past 3 years. The fund is a true value add investor with deep connections to academic institutions and opinion leaders.”
“OneVentures are a unique, one of a kind investor in the venture capital world. They put tremendous faith in their portfolio companys’ teams to deliver results, and are always on hand to provide pointed advice or step in to fill organizational gaps. BiVACOR has fortunately been part of the OneVentures family for nearly 4 years now, and their unyielding support has allowed our organization to pursue our dream of developing a practical replacement to the failing human heart. Without the OneVentures team, we would not be where we are today!”
Do you believe your company is a good fit to our investment mandate?
Our preference is for a warm introduction to be made through our network. You may know someone we’ve worked with before, otherwise the team is active at industry events – so come and say hello!
If this is not possible, please submit an application.
Learn about our other investment pillars below.
That’s why we apply a Responsible Investment filter to all prospective portfolio companies, especially seeking those that demonstrate strong ESG principles.
"*" indicates required fields
